Brodalumab | m-entrepreneurship.com

Product Name :
Brodalumab

Search keywords :
IL-17 Receptor A

drugId :
null

Target Vo:
Interleukin-17 receptor A

Target Vo Short Name :
IL17RA

Moa_Name:
Interleukin-17 receptor A antagonists

First Approval Country :
Japan

First Approval Date Filter:
2016

Origin Company_Name :
Amgen Inc

Active Company_Name :
Kyowa Kirin

Active Indication_Name:
Non-radiographic axial spondyloarthritis

In Active Indication_Name:
Crohn Disease

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD68 Antibody (YA798)
MEK1 Antibody
CD144/VE Cadherin Antibody: CD144/VE Cadherin Antibody is an unconjugated, approximately 86 kDa, rabbit-derived, anti-CD144/VE Cadherin polyclonal antibody. CD144/VE Cadherin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, background without labeling.

Author: Betaine hydrochloride

Related Posts